Annual EBIT
-$114.36 M
-$42.70 M-59.59%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual earnings before interest & taxes is -$114.36 million, with the most recent change of -$42.70 million (-59.59%) on December 31, 2023.
- During the last 3 years, EWTX annual EBIT has fallen by -$97.17 million (-565.18%).
- EWTX annual EBIT is now -1052.33% below its all-time high of -$9.92 million, reached on December 31, 2019.
Performance
EWTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$40.43 M
-$2.33 M-6.10%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly earnings before interest & taxes is -$40.43 million, with the most recent change of -$2.33 million (-6.10%) on September 30, 2024.
- Over the past year, EWTX quarterly EBIT has dropped by -$10.98 million (-37.28%).
- EWTX quarterly EBIT is now -1144.83% below its all-time high of -$3.25 million, reached on March 31, 2020.
Performance
EWTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$147.15 M
-$10.98 M-8.06%
September 30, 2024
Summary
- As of February 7, 2025, EWTX TTM earnings before interest & taxes is -$147.15 million, with the most recent change of -$10.98 million (-8.06%) on September 30, 2024.
- Over the past year, EWTX TTM EBIT has dropped by -$44.58 million (-43.46%).
- EWTX TTM EBIT is now -4430.60% below its all-time high of -$3.25 million, reached on March 31, 2020.
Performance
EWTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EWTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -59.6% | -37.3% | -43.5% |
| 3 y3 years | -565.2% | -37.3% | -43.5% |
| 5 y5 years | -1052.3% | -37.3% | -43.5% |
EWTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -164.6% | at low | -215.3% | at low | -240.5% | at low |
| 5 y | 5-year | -1052.3% | at low | -1144.8% | at low | -4430.6% | at low |
| alltime | all time | -1052.3% | at low | -1144.8% | at low | -4430.6% | at low |
Edgewise Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$40.43 M(+6.1%) | -$147.15 M(+8.1%) |
| Jun 2024 | - | -$38.11 M(+9.7%) | -$136.17 M(+10.3%) |
| Mar 2024 | - | -$34.75 M(+2.6%) | -$123.41 M(+7.9%) |
| Dec 2023 | -$114.36 M(+59.6%) | -$33.86 M(+15.0%) | -$114.36 M(+11.5%) |
| Sep 2023 | - | -$29.45 M(+16.2%) | -$102.57 M(+12.2%) |
| Jun 2023 | - | -$25.34 M(-1.4%) | -$91.38 M(+10.7%) |
| Mar 2023 | - | -$25.70 M(+16.4%) | -$82.54 M(+15.2%) |
| Dec 2022 | -$71.66 M | -$22.08 M(+20.9%) | -$71.66 M(+14.8%) |
| Sep 2022 | - | -$18.26 M(+10.7%) | -$62.40 M(+9.1%) |
| Jun 2022 | - | -$16.49 M(+11.2%) | -$57.22 M(+11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$14.83 M(+15.6%) | -$51.18 M(+18.4%) |
| Dec 2021 | -$43.22 M(+151.4%) | -$12.82 M(-1.9%) | -$43.22 M(+17.6%) |
| Sep 2021 | - | -$13.08 M(+25.0%) | -$36.74 M(+34.5%) |
| Jun 2021 | - | -$10.46 M(+52.5%) | -$27.30 M(+31.3%) |
| Mar 2021 | - | -$6.86 M(+8.1%) | -$20.80 M(+21.0%) |
| Dec 2020 | -$17.19 M(+73.2%) | -$6.34 M(+74.1%) | -$17.19 M(+58.5%) |
| Sep 2020 | - | -$3.64 M(-7.9%) | -$10.85 M(+50.6%) |
| Jun 2020 | - | -$3.96 M(+21.8%) | -$7.21 M(+121.8%) |
| Mar 2020 | - | -$3.25 M | -$3.25 M |
| Dec 2019 | -$9.92 M | - | - |
FAQ
- What is Edgewise Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual EBIT year-on-year change?
- What is Edgewise Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly EBIT year-on-year change?
- What is Edgewise Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM EBIT year-on-year change?
What is Edgewise Therapeutics annual earnings before interest & taxes?
The current annual EBIT of EWTX is -$114.36 M
What is the all time high annual EBIT for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual earnings before interest & taxes is -$9.92 M
What is Edgewise Therapeutics annual EBIT year-on-year change?
Over the past year, EWTX annual earnings before interest & taxes has changed by -$42.70 M (-59.59%)
What is Edgewise Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of EWTX is -$40.43 M
What is the all time high quarterly EBIT for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly earnings before interest & taxes is -$3.25 M
What is Edgewise Therapeutics quarterly EBIT year-on-year change?
Over the past year, EWTX quarterly earnings before interest & taxes has changed by -$10.98 M (-37.28%)
What is Edgewise Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of EWTX is -$147.15 M
What is the all time high TTM EBIT for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM earnings before interest & taxes is -$3.25 M
What is Edgewise Therapeutics TTM EBIT year-on-year change?
Over the past year, EWTX TTM earnings before interest & taxes has changed by -$44.58 M (-43.46%)